Skip to main content Skip to main navigation menu Skip to site footer
  • Home
  • Issues
    • Current
    • Archives
  • Author Guidelines
    • Writing Rules
    • Plagiarism Policy
    • Templates and Forms
    • Make a Submission
  • Reviewer Guideline
  • Indexing
  • Editorial Board
  • About
    • About the Journal
    • Aims & Scope
    • Ethical Principles and Publication Policy
    • Price Policy
    • Open Access Policy
    • Privacy Statement
    • License
    • Publisher
  • Contact
Search
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Vol. 1 No. 2 (2022): The Injector

Vol. 1 No. 2 (2022): The Injector

					View Vol. 1 No. 2 (2022): The Injector
Published: 2022-08-27

Original Article

  • Distribution and drug resistance of pathogens isolated from patients with hematological malignancies in three-year period Pathogens in hematological malignancies

    Çiğdem Arabacı, Mehmet Burak Aksu
    47-51
    • PDF
  • Risk factors, incidence and long-term outcomes of premature infants with retinopathy in a single tertiary clinic Premature infants with retinopathy

    Özge Begüm Comba, Muharrem Karakaya
    52-59
    • PDF
  • Does the balance of nitric oxide and L-arginine play a role in the development of allergic rhinitis? The balance of nitric oxide and L-arginine in allergic rhinitis

    Nihal Efe Atila, Tuğrul Çağrı Akman, Osman Nuri Aslan
    60-69
    • PDF
  • CMV colitis in children: Single-center experience CMV colitis in children

    Arzu Meltem Demir, Cansu Aydın, Burcu Hıdımoğlu, Selim Dereci, Saliha Kanık Yüksek, Esra Karakuş
    70-79
    • PDF
  • Assessment of tumor size changes following neoadjuvant chemotherapy for patients with N3 nasopharyngeal carcinoma Tumor size changes in N3 nasopharyngeal carcinoma

    Mustafa Akın, Mürsel Düzova
    80-83
    • PDF

Review

  • COVID-19 and headache COVID-19 and headache

    Gülhan Sarıcam
    84-89
    • PDF

Make a Submission

Make a Submission

Information

  • For Readers
  • For Authors
  • For Librarians

INDEXING AND ABSTRACTING

Announcements

CAS (The American Chemical Society)- A new database acceptance

February 3, 2025

The Injector was accepted to the CAS (The American Chemical Society) databases.

The Index Copernicus International Value (ICV) was released

September 27, 2024
The Index Copernicus Master Journal List editorial team has expressed their opinion about The Injector.

The Injector has been deemed worthy of 87.72 points (ICV-2023).

Publisher

Dr. Mustafa ŞAHİN, Hitit University Erol Olçok Training and Research Hospital, Çorum/Turkey

Most Read Articles (Last 30 days)
  • Is diabetes a risk factor in fungal infections?
    81
  • Evaluation of iron deficiency anemia in preterm and low birth weight infants
    71
  • The negative influence of Trichomonas vaginalis on pregnancy and treatment strategies.
    44
  • Multifocal nodular oncocytic hyperplasia clear cell variant: a rare case report of salivary gland lesion
    35
  • Auriculotherapy: A medical method in the diagnosis and treatment of diseases by using the auricle
    35
Keywords

The journal is licensed under a Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).

OJS Hosting, Support, and Customization by | OJS-Services.com

More information about the publishing system, Platform and Workflow by OJS/PKP.